Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes

Abstract Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment for myelodysplastic neoplasms (MDS). While matched sibling donors (MSD) have traditionally been preferred, the impact of donor type on transplant outcomes under anti-thymocyte globulin (ATG)-based...

Descripció completa

Dades bibliogràfiques

Autors principals:	So Yeon Park, Hyeji Lee, Daehun Kwag, Gi June Min, Sung Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Byung Sik Cho, Ki-Seong Eom, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Silvia Park, Yoo-Jin Kim
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2026-04-01
Col·lecció:	Annals of Hematology
Matèries:	Myelodysplastic syndromes Anti-thymocyte globulin Hematopoietic stem cell transplantation Donor selection
Accés en línia:	https://doi.org/10.1007/s00277-026-06999-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!